Glucose B. Braun Melsungen

Glucose B. Braun Melsungen is an intravenous solution that contains glucose monohydrate as its active ingredient. It is supplied in a sterile liquid form for infusion into the bloodstream, typically used in clinical settings across the EU. The product provides a source of carbohydrate energy and is formulated to be compatible with standard infusion equipment. It is packaged in single‑use containers that meet European pharmacopeial standards for purity and sterility.

Glucose B. Braun Melsungen is used in medical practice to supply carbohydrate calories and maintain fluid balance during various clinical situations.

- As an energy source during peri‑operative fasting. - To treat or prevent hypoglycemia in patients unable to eat. - As part of parenteral nutrition regimens for patients requiring intravenous caloric support. - For dilution and administration of other intravenous medications when a compatible carbohydrate solution is needed. - To provide free water and electrolytes in fluid replacement therapy.

The safety profile of Glucose B. Braun Melsungen reflects the typical reactions observed with intravenous glucose solutions, and most events are related to the carbohydrate load or the fluid volume administered.

Common: - Mild, transient elevation of blood glucose levels that usually resolves without intervention. - Slight increase in serum osmolality that is generally well tolerated. - Local irritation or erythema at the catheter insertion site. - Nausea, mild abdominal discomfort, or a feeling of fullness.

Serious: - Marked hyperglycemia that may require insulin therapy. - Significant electrolyte disturbances, especially hyponatremia or hyperkalemia. - Allergic responses ranging from urticaria to anaphylactic shock. - Fluid overload leading to pulmonary edema in patients with compromised cardiac or renal function.

When using Glucose B. Braun Melsungen, clinicians should consider several precautionary measures to ensure patient safety and therapeutic effectiveness.

- Assess baseline blood glucose and monitor levels during infusion. - Evaluate renal and cardiac function before large‑volume administration. - Adjust infusion rate in patients at risk for fluid overload. - Use compatible infusion sets to avoid precipitation with other drugs. - Avoid rapid infusion in neonates and infants. - Consider electrolyte status, especially sodium and potassium, before administration.

Glucose B. Braun Melsungen may interact with other intravenous agents, affecting drug stability or patient physiology.

Avoid: - Co‑administration with high‑dose insulin without appropriate glucose monitoring. - Mixing with calcium‑containing solutions that can cause precipitation. - Simultaneous infusion of potassium chloride in high concentrations, which may increase risk of hyperkalemia.

Use with caution: - Concurrent use of diuretics that may alter fluid and electrolyte balance. - Administration alongside medications that affect blood glucose, such as glucocorticoids. - Infusion with blood products, requiring careful monitoring of glucose levels.